679
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Exploring Work Productivity Loss in Patients With Inflammatory Bowel Disease

ORCID Icon, , , , , , , & show all
Article: FSO872 | Received 10 Jun 2022, Accepted 25 May 2023, Published online: 07 Jun 2023
 

Abstract

Aim: We aimed in this study to evaluate the impact of inflammatory bowel disease (IBD) on patients’ professional life and to determine predictors of severe work productivity loss (WPL). Materials & methods: A cross sectional study including patients with a confirmed diagnosis of IBD. Work productivity was evaluated with the work productivity and activity impairment score. Results: Severe absenteeism and WPL were found in respectively 7 (5.1%) and 54 (39.1%) patients. In multivariate analysis, the following features were found to be independently associated with severe WPL: penetrating Crohn’s disease (p: 0.001, OR: 6), anemia (p: 0.031, OR: 3.23), diarrhea (p < 0.001, OR: 11.23) and a secondary level of education (p: 0.003, OR: 1.95). Conclusion: Our results show that IBD have a substantial effect on patients’ professional life.

Plain Language Summary

Inflammatory bowel diseases (IBD) are chronic conditions that cause inflammation in the digestive system. We wanted to know how IBD affects people’s ability to work and what factors contribute to work difficulties. We asked adults with IBD about their education, work conditions and medical history. We found that a significant number of patients experience severe work productivity loss and absenteeism. Factors such as certain types of IBD, anemia, diarrhea and lower education level were linked to more severe work problems. These findings emphasize the impact of IBD on work life and highlight the importance of addressing these challenges in patient care.

Author contributions

S Nasr and W Dahmani: Manuscript drafting. H Jaziri, AB Slama: conception and design. A Hammami, WB Ameur: analysis and interpretation of the data. M Ksiaa, N Elleuch: critical revision of the article for important intellectual content. A Jmaa: final approval of the article.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

The authors state that they have obtained verbal and written informed consent from the patient/patients for the inclusion of their medical and treatment history within this case report.